Skip to content

Don’t be in the dark about AMD. Diagnose and treat AMD early.

Protect Your Patients

AdaptDx has really helped me care for my patients. It has helped me find macular degeneration a lot earlier and be able to proactively treat this for my patients.

Laurie Sorrenson, OD, FAAO Laurie Sorrenson, OD, FAAO View all testimonials
AdaptDx Scan

For Practices

Subclinical AMD Detection

Research reveals that Dark Adaptation™ is the earliest warning sign of AMD. Diagnosis at the subclinical level is the best chance to preserve vision.

AdaptDx Consult

For Patients

Protect Your Eyesight

Talking to your eye doctor about night blindness problems may help detect macular degeneration early enough to delay or prevent blindness.

Prevent Blindness Caused by AMD

With the AdaptDx®, you will be able to detect AMD at subclinical stage and manage this chronic progressive disease to prevent unnecessary vision loss.

Outside of the lane, there are four essential diagnostic tests that I couldn’t practice without: OCT, fundus camera, visual field, and the AdaptDx.

Glen Corbin, OD Glenn S. Corbin, OD View all testimonials

Latest News & Upcoming Events

View More
Press Releases: March 4, 2019

MacuLogix Raises $38.7 Million in Series D Financing Led by Vivo Capital

This funding will be used to further expand the team and company infrastructure to support the growing sales and practice integration efforts of the AdaptDx automated dark adaptometer.

Blog: February 28, 2019

Standing Out in the Crowd

The value we bring to eye care professionals’ practices is what makes us truly stand out in the crowd. By Armond Dantino.

Article: February 15, 2019 | Primary Optometry News

Dark Adaptation; A Biomarker for AMD

Practitioners can use the AdaptDx by Maculogix to test a patient’s dark adaptation, which can be a biomarker for AMD, according to Bill McPhee, CEO of Maculogix.